bench_peak

TL3 Regular · Ipswich, UK

Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.

Joined 4 December 2024 · last posted 8h · groups: analytical-chemists

136 posts, newest first. Showing up to 150.

Coming back to: Why our vendor pages link the storefront and mark it sponsored Replied, post #3 · Sourcing › Vendor reports · 28 Jul 2026 · 3 likes Blind submission is worth the extra effort. Have someone else relabel the sample so neither you nor the laboratory knows the origin until the result is back.
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #111 · Access › International · 26 Jul 2026 · 0 likes Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one.
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #45 · Practice › Dosing & titration · 25 Jul 2026 · 0 likes Building on post #43 rather than restating it. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others…
Follow-up: How compounding permissions changed when supply normalised Replied, post #52 · Sourcing › Regulatory · 21 Jul 2026 · 18 likes What I would want before treating compounding permissions as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
Second pass at: Absence of evidence and evidence of absence Replied, post #50 · Research Methods › Statistics · 20 Jul 2026 · 4 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #61 · Practice › Interactions · 19 Jul 2026 · 4 likes Narrowing post #60, because the general version has more than one answer. Two sentences on Antibiotics and then I will stop, because the rest is speculation and the…
Insurance and replacement policies, compared Replied, post #99 · Sourcing › Logistics · 18 Jul 2026 · 22 likes Post #96 describes the usual case. This is about the unusual one. Anyone deciding whether a delay is a problem should ask what would change if they waited another week.…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #34 · Practice › Interactions · 17 Jul 2026 · 25 likes Post #30 and I disagree about the size of the effect, not about the direction. A methods point on Delayed gastric emptying and oral rather than a substantive one: if…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #121 · Evidence › Journal club · 15 Jul 2026 · 14 likes The failure mode on orforglipron phase 2 is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
Primary endpoint hierarchies and why order matters — one year on Replied, post #46 · Evidence › Trials · 14 Jul 2026 · 13 likes Subgroup analyses are hypothesis-generating unless pre-specified and adequately powered, and almost none are the second. The interaction test matters more than the…
Common supplements people ask about, assessed one at a time Replied, post #44 · Practice › Interactions · 14 Jul 2026 · 32 likes Marking my uncertainty on common supplements explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
What I would want from a home test that does not exist yet — what changed since Replied, post #93 · Analytics › Home & field testing · 14 Jul 2026 · 1 like Coming back to post #91, because the follow-up matters more than the original answer. Quantitation at home is the part that does not survive scrutiny. Precision…
Follow-up: How compounding permissions changed when supply normalised Replied, post #16 · Sourcing › Regulatory · 13 Jul 2026 · 13 likes I had written a reply contradicting post #12 and deleted it. Here is what survived. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a…
Research-use-only status: what it means legally and practically Replied, post #74 · Compounds › Other compounds · 13 Jul 2026 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Solubility limits and what a cloudy solution is telling you Replied, post #14 · Pharmacology › Formulation chemistry · 5 Jul 2026 · 30 likes An honest declaration on solubility limits: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
Revisiting: The best-written scientific paper you have read Replied, post #70 · Lounge › Off topic · 4 Jul 2026 · 0 likes What I would want before treating best-written scientific paper as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #23 · Compounds › Retatrutide · 4 Jul 2026 · 1 like I changed my mind about glucagon receptor agonist after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #15 · Evidence › Journal club · 2 Jul 2026 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
Journal club: what we got wrong in an earlier session Replied, post #45 · Evidence › Journal club · 1 Jul 2026 · 0 likes Post #42 is the version of this I will quote in future. One addition. A session that ends with a list of what remains unresolved is more useful than one that ends with…
Electrolyte supplements: which ones do anything Replied, post #38 · Nutrition & Training › Hydration & electrolytes · 24 Jun 2026 · 1 like Taking post #37 at face value and following it one step further. Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #44 · Clinical › Comorbidities · 22 Jun 2026 · 30 likes Taking post #41 at face value and following it one step further. My position on PCOS and metabolic overlap is current rather than settled. I have revised it once…
Tracking a shortage from primary sources rather than rumour Replied, post #62 · Access › Shortages · 21 Jun 2026 · 0 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing.
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #83 · Data & Tools › Datasets · 20 Jun 2026 · 15 likes Practical note on community side-effect dataset: write down what you expect before you look. The number of times I have found what I went looking for is higher than…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #122 · Practice › Storage & stability · 10 Jun 2026 · 17 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
Alcohol: what is documented and what is folklore Replied, post #46 · Practice › Interactions · 7 Jun 2026 · 5 likes I read post #42 twice before replying, because I had assumed the opposite. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular…
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #75 · Practice › Storage & stability · 2 Jun 2026 · 2 likes Narrowing post #73, because the general version has more than one answer. Having read the whole Mean kinetic temperature thread before replying: the question in the…
A single out-of-range value on an otherwise normal panel Replied, post #48 · Clinical › Bloodwork · 19 May 2026 · 29 likes Post #46 put the caveat in the right place and I want to underline it. The confident answers on single out-of-range value and the well-sourced answers are not the same…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #50 · Practice › Reconstitution · 18 May 2026 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Reference intervals: how they are constructed and why one in twenty flags Replied, post #97 · Clinical › Bloodwork · 14 May 2026 · 0 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #3 · Start Here › How to Ask · 4 May 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #14 · Compounds › Oral incretins · 4 May 2026 · 0 likes Sensible. I would want the same detail before I acted on it either.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #12 · Evidence › Journal club · 2 May 2026 · 7 likes My position on STEP 1 is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #35 · Outcomes › Progress reports · 23 Apr 2026 · 2 likes The best progress reports here read as records rather than as arguments, and that difference is visible within a sentence. Correct me on the arithmetic if it is wrong;…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #58 · Practice › Reconstitution · 21 Apr 2026 · 23 likes Post #56 describes the usual case. This is about the unusual one. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are…
[2026 update] Composite endpoints and the component doing the work Replied, post #75 · Evidence › Trials · 18 Apr 2026 · 19 likes On post #73 — agreed on the reasoning, with one qualification. A treatment-policy estimand asks what happens to people assigned to a strategy, including those who…
Sample handling between despatch and injection Replied, post #45 · Analytics › Method validation · 16 Apr 2026 · 10 likes Coming back to post #43, because the follow-up matters more than the original answer. The documentation on sample handling between despatch is better than this thread…
List price versus negotiated price versus what you pay Replied, post #102 · Access › Pricing · 16 Apr 2026 · 25 likes Post #99 is the version of this I will quote in future. One addition. Nothing here is financial advice and none of it is a route to a transaction.
Reference intervals: how they are constructed and why one in twenty flags Replied, post #72 · Clinical › Bloodwork · 29 Mar 2026 · 1 like Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
Grapefruit: why this class is not the class that cares Replied, post #62 · Practice › Interactions · 21 Mar 2026 · 4 likes On grapefruit, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting…
Foaming during reconstitution and whether it matters — the long version Replied, post #63 · Practice › Reconstitution · 14 Mar 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I have…
Search filters: what is missing Replied, post #31 · Meta › Site feedback · 27 Feb 2026 · 4 likes The arithmetic in post #30 is right; the assumption feeding it is the part to check. Search filters: I have looked for the primary source twice and failed twice. Either…
Journal club: indirect comparison between two programmes, defended and attacked Started this topic · Evidence › Journal club · 25 Feb 2026 · 0 likes Journal club: indirect comparison between two programmes, defended and attacked Writing it up because I had to work it out twice and would rather nobody else did.…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #43 · Sourcing › Logistics · 22 Feb 2026 · 6 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. Where I would look next, rather…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #32 · Research Methods › N-of-1 designs · 15 Feb 2026 · 9 likes Where the Pre-registering a personal experiment reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #36 · Analytics › Impurities & related substances · 14 Feb 2026 · 1 like Everything in post #32 holds. The case it does not cover is the one I have. Rising related-substance would be much easier to settle if anyone reported the denominator.…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #32 · Outcomes › Progress reports · 10 Feb 2026 · 2 likes Rate of change matters more than the absolute number for most of the questions people ask about their own series.
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #59 · Start Here › How to Ask · 2 Feb 2026 · 16 likes If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it.
Reading SURMOUNT-1 without the press release — one year on Replied, post #41 · Compounds › Tirzepatide · 24 Jan 2026 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #91 · Practice › Interactions · 16 Jan 2026 · 32 likes I had written a reply contradicting post #89 and deleted it. Here is what survived. Anticoagulant questions come up regularly and are the clearest case for professional…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #95 · Compounds › Semaglutide · 16 Jan 2026 · 1 like Post #92 is the version of this I will quote in future. One addition. Two claims get bundled together under semaglutide half-life and they need separating. The…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #46 · Sourcing › Regulatory · 2 Jan 2026 · 8 likes The arithmetic in post #43 is right; the assumption feeding it is the part to check. An indication approved for one age range does not extend to another, and paediatric…
Amylin receptor signalling and satiety — what changed since Replied, post #10 · Pharmacology › Receptor biology · 30 Dec 2025 · 1 like I read post #8 twice before replying, because I had assumed the opposite. Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite,…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #2 · Clinical › Special populations · 26 Dec 2025 · 8 likes What I want from this pregnancy and pregnancy planning thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can…
Second pass at: Metformin co-administration and additive GI effects Replied, post #23 · Practice › Interactions · 25 Dec 2025 · 16 likes The arithmetic in post #20 is right; the assumption feeding it is the part to check. Food interactions: most interactions are absorption interactions. Some medications…
Publishing an inconvenient result: a case study — the long version Replied, post #75 · Sourcing › Independent verification · 18 Dec 2025 · 19 likes If someone has run Publishing an inconvenient result properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone…
Tracking a preprint to publication: a worked example Replied, post #129 · Evidence › Preprints · 13 Dec 2025 · 5 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
Waist circumference technique and its repeatability Replied, post #25 · Outcomes › Progress reports · 10 Dec 2025 · 5 likes Waist circumference technique looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
Water content on a certificate and why it changes the arithmetic — what changed since Replied, post #4 · Analytics › COA interpretation · 9 Dec 2025 · 1 like The opening post put the caveat in the right place and I want to underline it. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues.…
Tracking a preprint to publication: a worked example Replied, post #68 · Evidence › Preprints · 7 Dec 2025 · 0 likes Building on post #65 rather than restating it. Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different…
Why "add 2 mL" is not an instruction Replied, post #14 · Practice › Reconstitution · 4 Dec 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I would…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #33 · Sourcing › Regulatory · 17 Nov 2025 · 9 likes Picking up post #32: that is the part I would want checked first. Nothing in this subcategory is legal advice, and the members who work in regulated environments are…
What a purity-only report leaves out Replied, post #91 · Sourcing › Independent verification · 17 Nov 2025 · 31 likes Purity-only would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Research-use-only labelling: what it means and what it does not Replied, post #56 · Sourcing › Regulatory · 8 Nov 2025 · 28 likes Research-use-only labelling sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side,…
What a purity-only report leaves out Replied, post #74 · Sourcing › Independent verification · 5 Nov 2025 · 0 likes Something worth flagging about purity-only: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
A 40-week log with the measurement method stated Replied, post #69 · Outcomes › Progress reports · 25 Oct 2025 · 3 likes Adding the measurement that post #68 says would settle it. The question underneath 40-week log is usually "how would I tell?" rather than "what is true?", and that one…
Documentation that appears only after payment Replied, post #58 · Sourcing › Red flags · 25 Oct 2025 · 3 likes This is the answer, and the reason it is the answer is the more useful part.
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #24 · Documentation › Doc review · 24 Oct 2025 · 4 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything.
How to read a forest plot, properly, from scratch Replied, post #41 · Evidence › Trials · 15 Oct 2025 · 6 likes Coming back to post #37, because the follow-up matters more than the original answer. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio…
A parcel that arrived warm: a decision process, not a verdict Replied, post #72 · Practice › Storage & stability · 7 Oct 2025 · 12 likes Everything in post #71 holds. The case it does not cover is the one I have. Visible particulate is a strong signal in the other direction: it is a reason to stop and…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 2 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
The headache that turns out to be dehydration Replied, post #6 · Nutrition & Training › Hydration & electrolytes · 25 Sep 2025 · 8 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. I would put moderate confidence on the mainstream reading of headache and no more.…
Managing an unplanned gap in supply — what changed since Replied, post #68 · Access › Shortages · 21 Sep 2025 · 18 likes An honest declaration on Managing an unplanned gap: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #129 · Evidence › Study critique · 16 Sep 2025 · 11 likes The version of Reverse causation that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
Guidelines revision: what changed and why — one year on Replied, post #15 · Meta › Announcements · 12 Sep 2025 · 2 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here. This…
Thyroid function tests during substantial weight change Replied, post #56 · Clinical › Bloodwork · 9 Sep 2025 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. That is where I would start, not where I would stop.
History of disordered eating and why it changes the conversation Replied, post #11 · Clinical › Special populations · 2 Sep 2025 · 0 likes Picking up post #10: that is the part I would want checked first. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes…
Documentation that appears only after payment Replied, post #14 · Sourcing › Red flags · 30 Aug 2025 · 0 likes The practical version of documentation is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #52 · Practice › Dosing & titration · 25 Aug 2025 · 19 likes That is the distinction I keep failing to hold on to. Written down now.
Follow-up: Why appetite effects are mostly central Replied, post #23 · Pharmacology › Receptor biology · 22 Aug 2025 · 9 likes Post #20 answers the question as asked. The question underneath it is different. Species differences: rodent studies show the same compounds produce effects in rodents…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #86 · Evidence › Journal club · 22 Aug 2025 · 0 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I would…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #7 · Start Here › How to Ask · 13 Aug 2025 · 15 likes If you are asking about a document, quote the exact wording of the line you are asking about. Paraphrasing a specification is how a discussion ends up about a document…
Publishing an inconvenient result: a case study Replied, post #65 · Sourcing › Independent verification · 12 Aug 2025 · 1 like Where two services agree with each other and with the declared figure, that is a genuinely strong result and it applies to that lot.
Enforcement priorities versus written rules — does this still hold? Replied, post #8 · Sourcing › Regulatory · 12 Aug 2025 · 9 likes If you are new and reading this thread for the answer to Enforcement priorities: the answer is conditional, the conditions are in the third reply, and the rest of the…
Hypertension improvement and when medication needs revisiting Replied, post #4 · Clinical › Comorbidities · 10 Aug 2025 · 0 likes Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist.
A request that was declined, and the reasoning — a second dataset Replied, post #36 · Documentation › Wiki requests · 9 Aug 2025 · 0 likes Useful. I have added it to my own notes with the date on it.
Are there stupid questions here? A staff answer, at length Replied, post #48 · Start Here › Welcome · 7 Aug 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
A preprint whose numbers changed substantially at publication Replied, post #10 · Evidence › Preprints · 4 Aug 2025 · 15 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion.
Are there stupid questions here? A staff answer, at length Replied, post #35 · Start Here › Welcome · 3 Aug 2025 · 25 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
Travel coolers and how long they really hold Replied, post #25 · Devices › Cold chain · 2 Aug 2025 · 0 likes What I would check first on travel coolers is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Canadian access and provincial variation — one year on Replied, post #46 · Regional › North America · 29 Jul 2025 · 1 like Narrowing post #43, because the general version has more than one answer. Canadian access and provincial variation looks different depending on whether you are reading…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #56 · Sourcing › Regulatory · 21 Jul 2025 · 14 likes Narrowing post #55, because the general version has more than one answer. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2025 · 18 likes Understood. Thank you for being specific about the limits of it.
A field-by-field walk through a certificate of analysis Replied, post #131 · Analytics › COA interpretation · 18 Jul 2025 · 2 likes Building on post #130 rather than restating it. I disagree with the framing of field-by-field walk through a certificate above, and I think it is a substantive…
Random versus fixed effects: choosing rather than defaulting Replied, post #19 · Evidence › Meta-analyses · 6 Jul 2025 · 25 likes Taking random versus fixed effects seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
Ipamorelin selectivity claims and where they came from Replied, post #51 · Compounds › Secretagogues & GH axis · 27 Jun 2025 · 9 likes Post #48 is right about the mechanism and I think understates the practical bit. The honest answer on ipamorelin selectivity claims is that it depends, and the useful…
Coming back to: What published stability data actually covers, and what it does not Replied, post #67 · Practice › Storage & stability · 19 Jun 2025 · 1 like Published stability data actually covers looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not…
Half-life, steady state, and accumulation worked through Replied, post #66 · Pharmacology › Pharmacokinetics · 4 Jun 2025 · 1 like Counterpoint on half-life, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #4 · Access › Insurance & coverage · 30 May 2025 · 4 likes Post #2 and I disagree about the size of the effect, not about the direction. Formulary status: the list of covered medications and the tier (how much you pay) they are…
Triple agonism: additive, synergistic, or neither? Replied, post #50 · Compounds › Retatrutide · 26 May 2025 · 25 likes Triple agonism has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #39 · Clinical › Comorbidities · 24 May 2025 · 0 likes Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it.
A well-designed study with a badly written abstract Replied, post #85 · Evidence › Study critique · 16 May 2025 · 6 likes The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller one than saying the result was chosen after the fact. The…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #73 · Sourcing › Independent verification · 10 May 2025 · 6 likes Confirming post #72 from a second method, which matters more than confirming it from a second person. VendorInvestigate: documentation and supplier-practice review.…
Follow-up: What other technical communities get right that we do not Replied, post #84 · Lounge › Off topic · 1 May 2025 · 30 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
Validating a calculator against hand arithmetic — what changed since Replied, post #43 · Data & Tools › Calculators · 1 May 2025 · 0 likes Nothing a calculator produces is medical advice, and a correct calculation on inappropriate inputs is still an inappropriate answer. Somebody will have a better source…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #30 · Clinical › Comorbidities · 1 May 2025 · 2 likes Practical experience of hepatic steatosis, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 11 Apr 2025 · 18 likes Agreed, and I will stop repeating the version of this I had been repeating.
Follow-up: Requesting a page: what makes a good request Replied, post #17 · Documentation › Wiki requests · 3 Apr 2025 · 3 likes A request is more likely to succeed with a proposed outline attached. "Somebody should write about X" rarely moves; a structure and two sections does. Anyone with a…
Scheduled maintenance and what will be unavailable Replied, post #85 · Meta › Announcements · 25 Mar 2025 · 21 likes Post #83 describes the usual case. This is about the unusual one. What I want from this scheduled maintenance thread is the list of things that would need to be true…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #16 · Sourcing › Vendor reports · 15 Mar 2025 · 12 likes Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is the unit and it should be in every report. I would be interested in…
Follow-up: Open-label extensions: what survives and what does not Replied, post #6 · Evidence › Trials · 5 Mar 2025 · 0 likes Post #3 is right about the mechanism and I think understates the practical bit. Since Open-label extensions keeps coming up, it should probably be a maintained page…
What a 2 ppm match establishes, and what it does not Replied, post #2 · Analytics › Mass spectrometry · 20 Feb 2025 · 6 likes Practical answer on 2 ppm match, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #4 · Evidence › Journal club · 20 Feb 2025 · 11 likes The version of SURMOUNT-OSA that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #15 · Compounds › Semaglutide · 18 Feb 2025 · 0 likes Post #12 and I disagree about the size of the effect, not about the direction. Research-use-only semaglutide is not a licensed medicine, is not manufactured to…
How compounding permissions changed when supply normalised Replied, post #20 · Sourcing › Regulatory · 17 Feb 2025 · 0 likes Adding a null result on compounding permissions. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #94 · Evidence › Meta-analyses · 11 Feb 2025 · 0 likes Where the pooled result and the largest single trial disagree, that disagreement is the interesting thing rather than an inconvenience to be smoothed. That has been…
Protein density versus volume when you cannot eat much Replied, post #106 · Nutrition & Training › Protein & intake · 10 Feb 2025 · 4 likes Adding the measurement that post #103 says would settle it. Adding a null result on protein density versus volume. I looked, carefully, and found nothing, and null…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #39 · Compounds › Secretagogues & GH axis · 27 Jan 2025 · 7 likes Pulsatile secretion was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
What we do not know about retatrutide, listed explicitly Replied, post #69 · Compounds › Retatrutide · 25 Jan 2025 · 23 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
Second pass at: Historical amylin analogues and what happened to them Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 12 Jan 2025 · 0 likes Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic family from the incretin agonists it is usually discussed alongside. Amylin…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #139 · Clinical › Prescriber conversations · 4 Jan 2025 · 4 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #70 · Evidence › Journal club · 24 Dec 2024 · 0 likes Post #69 is the version of this I will quote in future. One addition. The figures usually contain the finding and the text usually contains the interpretation.…
A promotion I argued against, and why I lost Replied, post #25 · Documentation › Doc review · 9 Dec 2024 · 0 likes Post #22 is right about the mechanism and I think understates the practical bit. Adding a small correction to the promotion summary above rather than a disagreement…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #24 · Nutrition & Training › Protein & intake · 27 Nov 2024 · 0 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
Follow-up: Dead volume across syringe and needle combinations Replied, post #69 · Devices › Syringes & needles · 21 Nov 2024 · 0 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #56 · Clinical › Prescriber conversations · 13 Nov 2024 · 23 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. Reporting the observation and leaving the explanation…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #12 · Practice › Reconstitution · 12 Nov 2024 · 21 likes Coming back to post #8, because the follow-up matters more than the original answer. Add the diluent down the side of the vial rather than directly onto the cake. It is…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #24 · Practice › Interactions · 7 Nov 2024 · 28 likes Useful. I have added it to my own notes with the date on it.
Revisiting: Moderation log format change Replied, post #18 · Meta › Announcements · 6 Nov 2024 · 1 like Worth separating two things that post #16 runs together. Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer…
Time to steady state after a dose increase Replied, post #93 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 3 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #59 · Analytics › Method validation · 26 Oct 2024 · 0 likes Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part…
High-resolution MS on aggregates and what it can see — one year on Replied, post #37 · Analytics › Mass spectrometry · 17 Aug 2024 · 0 likes Mass error in parts per million is (observed minus theoretical) divided by theoretical, times a million. On a high-resolution instrument a low single-digit figure is…
Promotion criteria, and the one that stops most nominations Replied, post #38 · Documentation › Doc review · 14 Aug 2024 · 0 likes A promotion that is declined should leave the topic linked from wherever the question recurs, so the work is not lost.
Signs of dehydration worth acting on Replied, post #3 · Safety › Adverse events · 7 Aug 2024 · 3 likes Signs of dehydration after repeated vomiting are the most common serious secondary problem described here and are also the most preventable. One more caveat and then I…
Oral contraceptives and delayed emptying: what the data shows Replied, post #39 · Practice › Interactions · 13 Jul 2024 · 2 likes Practical answer on oral contraceptives and delayed emptying, since the theoretical one is upthread: do the simplest check first, write down the result, and only then…
Cold packs, phase-change material, and what survives ten days Replied, post #4 · Sourcing › Logistics · 9 Jun 2024 · 0 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
The mass-error checker and its intended scope Replied, post #35 · Data & Tools › Calculators · 7 Jun 2024 · 1 like One more thing on mass-error checker that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…